From fundamental mechanisms to translational breakthroughs — three days of expert-curated science spanning basic research to clinical practice.
Fundamental research in itch neurobiology, molecular mechanisms, sensory neuroscience, and animal models.
Evidence-based diagnosis, management strategies, case studies, and clinical guidelines for chronic pruritus.
Bridging the gap from preclinical discovery to human applications and therapeutic validation.
Pharmaceutical innovations, drug pipelines, regulatory updates, and sponsored educational symposia.
Welcome delegates and informal networking breakfast in the foyer.
IFSI President · Congress Chairs · Local Hosts
Chair: Prof. David Kim · Speaker: Dr. Anna Müller, University of Heidelberg
Industry exhibition open. Dedicated time with scientific poster boards.
Four rapid presentations on itch-specific neuronal circuits, TRP channels, and spinal processing.
Optional satellite on targeted monoclonal antibody therapies in AD-associated pruritus.
Track A: Inflammatory pathways in atopic dermatitis
Track B: Itch in systemic disease (renal, hepatic, haematological)
Educational sessions by WCI Platinum Sponsors on pipeline drugs and real-world evidence.
Networking reception in the Congress Centrum atrium. All delegates welcome.
Chair: Dr. Maria Gonzalez · Speaker: Prof. Kenji Tanaka, Tokyo Medical University
Biologics, JAK inhibitors, and novel receptor-targeted approaches.
Speakers: Dr. Anna Müller · Dr. Maria Gonzalez
Expert panel discussions on complex diagnostic and therapeutic challenges.
Over 80 poster presentations with author-guided tours.
Multi-expert panel exploring unmet needs and global collaboration opportunities.
Annual congress dinner in historic Heidelberg. By invitation / separate registration.
Latest phase III trial readouts and FDA/EMA regulatory updates.
Novel preclinical and translational findings across rodent models, organoids, and human tissue.
Second poster tour featuring oral abstract competition finalists.
Top three early-career researchers present their prizewinning research. Award ceremony follows.
Panel defining priorities for the next decade of itch research and global collaboration.
Closing address, recognition of outstanding contributions, and next WCI location announcement.
Exploring emerging therapeutic strategies — biologics, targeted therapies, and novel clinical approaches translating bench discoveries directly to bedside practice.
University of Heidelberg
Neuroimmune Pathways in Chronic Itch
Harvard Medical School
Advances in Targeted Therapies
Clinical Research Institute
Patient-Centered Treatment Models
Tokyo Medical University
Translational Itch Research
120+ confirmed speakers · Full list available in the congress app from August 2027
Submit your abstract and join the world's leading itch scientists on the WCI 2027 platform.